Establishment and characterization of acquired resistance to platinum anticancer drugs in human ovarian carcinoma cells.
about
The anti-HIV cytokine midkine binds the cell surface-expressed nucleolin as a low affinity receptorA phase I study and pharmacologic evaluation of irinotecan and carboplatin for patients with advanced ovarian carcinoma who previously received platinum-containing chemotherapy.Irinotecan plus carboplatin for patients with carcinoma of unknown primary site.Combination of irinotecan and platinum for platinum-resistant or refractory recurrent ovarian cancers: A preliminary case series.Relationship between folate-binding protein expression and cisplatin sensitivity in ovarian carcinoma cell lines.PRIMA-1MET induces apoptosis through accumulation of intracellular reactive oxygen species irrespective of p53 status and chemo-sensitivity in epithelial ovarian cancer cellsComparison of prognoses according to non-positive and positive spectrin αII expression detected immunohistochemically in epithelial ovarian carcinoma: a retrospective study.Common biological phenotypes characterize the acquisition of platinum-resistance in epithelial ovarian cancer cells.Association between expression of the MRP3 gene and exposure to platinum drugs in lung cancer.A phase I clinical and pharmacologic study of a carboplatin and irinotecan regimen combined with recombinant human granulocyte-colony stimulating factor in the treatment of patients with advanced nonsmall cell lung carcinoma.
P2860
Q28216327-8E878784-4EC3-4A12-8731-5DA7462FDBBFQ33367493-1A8C06B9-EE5F-49AE-AA6B-DD3CF422B3EBQ33382477-565EC3A8-AF72-4769-A455-B5CB183E5050Q33858199-A4EF3845-F591-4B55-9293-3F67D03744DAQ36422416-8B054AFB-22C1-46CE-B221-CE644A01F386Q36738640-E70AB11A-0FA4-4685-8DBE-41972BC39400Q37045532-159FEC38-A9ED-46B3-8579-1AC19C3DB242Q38695855-F82C384D-6E2D-44A9-8495-C3EB4BADA2D3Q43690852-4BA77159-3956-41EA-835C-A815972434FCQ48017892-8C287776-DF17-4FB0-B278-661E4CA49272
P2860
Establishment and characterization of acquired resistance to platinum anticancer drugs in human ovarian carcinoma cells.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Establishment and characteriza ...... human ovarian carcinoma cells.
@en
type
label
Establishment and characteriza ...... human ovarian carcinoma cells.
@en
prefLabel
Establishment and characteriza ...... human ovarian carcinoma cells.
@en
P2093
P2860
P1476
Establishment and characteriza ...... human ovarian carcinoma cells.
@en
P2093
K Higashide
N Suganuma
P2860
P356
10.1111/J.1349-7006.1995.TB02992.X
P577
1995-01-01T00:00:00Z